EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease

Hyo-Seung Nam, Yein Oh

Veterinary Research Communications · 2026

DOI: 10.1007/s11259-026-11358-2 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Veterinary Research Communications, 2026. Verfasst von Hyo-Seung Nam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dasom Animal Medical Center, Busan, 48415, Republic of Korea. Hauptthemen laut MEDLINE: Dog Diseases, Mitral Valve Insufficiency, Cardiomegaly, Adrenocortical Hyperfunction. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this case report, we describe an atypical clinical course in a dog with preexisting myxomatous mitral valve disease (MMVD) subsequently complicated by the development of hyperadrenocorticism. Typically, hyperadrenocorticism can exacerbate cardiac conditions; however, this dog demonstrated paradoxical improvement. A retrospective analysis of the clinical, radiographic, echocardiographic, and hormonal data was conducted to investigate the marked reduction in cardiac size in a Maltese dog with MMVD following the diagnosis of hyperadrenocorticism. A 10-year-old spayed female Maltese dog presented with dyspnea. The initial clinical presentation, diagnosis of MMVD, subsequent identification of hyperadrenocorticism, and observed changes in cardiac size were comprehensively documented. At initial presentation, the dog exhibited severe cardiomegaly and left-sided heart failure due to mitral valve prolapse associated with MMVD and resulting severe mitral regurgitation. Nineteen months later, hyperadrenocorticism was diagnosed. Subsequent echocardiography revealed ventricular hypertrophy and diastolic dysfunction, which may have contributed to changes in mitral valve geometry and reduced mitral regurgitation. Echocardiography revealed a significant reduction in cardiomegaly and an improvement in hemodynamic parameters. Diuretic therapy was gradually discontinued, and the dog was successfully managed with pimobendan and trilostane. This case report highlights the complex interplay between hyperadrenocorticism and MMVD and demonstrates an atypical clinical outcome characterized by cardiac improvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesMitral Valve InsufficiencyCardiomegalyAdrenocortical HyperfunctionMitral Valve ProlapseAnimalsDogsFemaleDihydrotestosteronePyridazinesEchocardiography

Stichwörter der Autor:innen

CardiomegalyHyperadrenocorticismMyocardial hypertrophyMyxomatous mitral valve diseaseReverse remodeling

Substanzen

pimobendanDihydrotestosteronetrilostanePyridazines

Autor:innen und Institutionen

  • Dasom Animal Medical Center, Busan, 48415, Republic of Korea.
  • Department of Veterinary Internal Medicine, College of Veterinary Medicine and Institute for Veterinary Biomedical Science, Kyungpook National University, Daegu, 41566, Republic of Korea.
  • Department of Veterinary Internal Medicine, College of Veterinary Medicine and Institute for Veterinary Biomedical Science, Kyungpook National University, Daegu, 41566, Republic of Korea. imyein5@knu.ac.kr.

Zitieren

APA

Nam, H. S., & Oh, Y. (2026). Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease. Veterinary Research Communications. https://doi.org/10.1007/s11259-026-11358-2

Vancouver

Nam HS, Oh Y. Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease. Veterinary Research Communications. 2026. doi:10.1007/s11259-026-11358-2

BibTeX
@article{Nam2026,
  author = {Nam, Hyo-Seung and Oh, Yein},
  title = {Paradoxical improvement of mitral regurgitation associated with hyperadrenocorticism-related cardiac hypertrophy in a dog with myxomatous mitral valve disease},
  journal = {Veterinary Research Communications},
  year = {2026},
  doi = {10.1007/s11259-026-11358-2}
}
Kostenlos starten →